Synthetic K3 and D-Fraction Kill Cancer Cell In Vitro

Alternative Therapeutic Approach to Renal Cell Ca… [J Endourol. 2013] – PubMed – NCBI

woman with pill

Renal cell carcinoma has a poor outcome and since there is little to do therapeutically the researches tried an alternative approach to treatment of the cancer in vitro (in a test tube).

The researchers used menadione a synthetic vitamin K3 and D-fraction a mushroom extract. What the researchers found was that the menadione was able to reduce cancer cell viability by 20% while the D-fraction reduced it 20-45%. However the real results were seen when the menadione and the D-fraction were combined. The combination resulted in a 90% reduction in cell viability.

While these results still need human trials it does give hope that this combination could be a viable therapeutic modality for renal cell carcinoma.


Sharing This

About John Montague DC

John Montague DC is the owner of WebVitamins. He is active in the industry and is currently president of the NPA East.

Speak Your Mind


Sharing This

facebooktwittergoogle_pluspinterestmailby feather